Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic chagas disease;Valoración de anticuerpos con reactividad cruzada patógeno-huésped en pacientes con diferentes estadios de cardiopatía chagásica crónica

Revista Espanola de Cardiologia

Volumn 66, Issue 10, 2013, Pages 791-796

  Vicco, Miguel H ^a,b   Ferini, Franco ^b   Rodeles, Luz ^b   Cardona, Paula ^a   Bontempi, Iván ^a   Lioi, Susana ^c   Beloscar, Juan ^c   Nara, Takeshi ^d   Marcipar, Iván ^a   Bottasso, Oscar A ^c  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Hospital JBIturraspe Santa Fe   (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Anti B13 autoantibodies; Chagas disease; Heart failure; Trypanosoma cruzi

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; CROSS REACTING ANTIBODY; PROTOZOON ANTIBODY;

ARTICLE; CHAGAS DISEASE; ELECTROCARDIOGRAPHY; HUMAN; MORTALITY; ADULT; AGED; CHRONIC DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL; TRYPANOSOMA CRUZI;

ADULT; AGED; ANTIBODIES, PROTOZOAN; AUTOANTIBODIES; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOST-PATHOGEN INTERACTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRYPANOSOMA CRUZI;

EID: 84884702356     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.05.028     Document Type: Article

References (45)

1. Control of Chagas disease: second report of a WHO expert committee World Health Organ Tech Rep Ser 905 2002 1 109
2. Organización Panamericana de la Salud. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo, Uruguay: OMS; 2006.
3. J.A. Marin-Neto, and A. Rassi Jr. Actualización sobre la cardiopatía de la enfermedad de Chagas en el primer centenario de su descubrimiento Rev Esp Cardiol 62 2009 1211 1216
4. C.A. Da Silva, A. Fattori, A.L. Sousa, S.B. Mazon, S. Monte Alegre, and E.A. Almeida Determinación de la concentración plasmática de proteína C reactiva en pacientes con diferentes formas clínicas de la enfermedad de Chagas Rev Esp Cardiol 63 2010 1096 1099
5. H.O. Almeida, V.P.A. Teixeira, M.A. Dos Reis, J.U. Franciscon, and E. Martins Modificações nucleares em células parasitadas pelo Trypanosoma cruzi em chagásicos crônicos Rev Soc Bras Med Trop 20 1987 147 151
6. H.O. Almeida, M.C. Brandão, M.A. Dos Reis, H. Gobbi, and V.P.A. Teixeira Denervação e cardiopatia no chagásico crônico Arq Bras Cardiol 48 1987 43 47
7. N. Gironès, and M. Fresno Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol 19 2003 19 22
8. J. Kalil, and E. Cunha-Neto Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last? Parasitol Today 12 1996 396 399
9. J.S. Leon, and D.M. Engman Autoimmunity in Chagas heart disease Int J Parasitol 31 2001 555 561
10. Z. Brener, and R.T. Gazzinelli Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease Int Arch Allergy Immunol 114 1997 103 110
11. M.L. Higuchi, C.F. De Morais, A.C. Pereira Barreto, E.A. Lopes, N. Stolf, and G. Bellotti The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies Clin Cardiol 10 1987 665 670
12. L. Pontes-de-Carvalho, C.C. Santana, M.B. Soares, G.G. Oliveira, E. Cunha-Neto, and R. Ribeiro-dos-Santos Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens J Autoimmun 18 2002 131 138
13. M.B. Soares, L. Pontes-de-Carvalho, and R. Ribeiro-dos-Santos The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet An Acad Bras Cienc 73 2001 547 559
14. J.R. Coura, and P.A. Viñas Chagas disease: a new worldwide challenge Nature 465 2010 S6 S7
15. J.R. Coura, and J. Borges-Pereira Chagas disease: 100 years after its discovery. A systemic review Acta Trop 115 2010 5 13
16. E. Cunha-Neto, P.C. Teixeira, L.G. Nogueira, and J. Kalil Autoimmunity Adv Parasitol 76 2011 129 152
17. G. Cremaschi, M. Fernández, G. Gorelik, J. Goin, C. Fossati, and N. Zwirner Modulatory effects on myocardial physiology induced by an anti- monoclonal antibody involve recognition of major antigenic epitopes from ß-adrenergic and M-muscarinic cholinergic receptors without requiring receptor cross-linking J Neuroimmunol 153 2004 99 107
18. L. Joensen, E. Borda, T. Kohout, S. Perry, G. García, and L. Sterin-Borda Trypanosoma cruzi antigen that interacts with the ß1-adrenergic receptor and modifies myocardial contractile activity Mol Biochem Parasitol 127 2003 169 177
19. I. Ferrari, M.J. Levin, G. Wallukat, R. Elies, D. Lebesgue, and P. Chiale Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor J Exp Med 182 1995 59 65
20. V. Labovsky, C.R. Smulski, K. Gómez, G. Levy, and M.J. Levin Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease Clin Exp Immunol 148 2007 440 449
21. V. Grippo, L.L. Niborski, K.A. Gomez, and M.J. Levin Human recombinant antibodies against Trypanosoma cruzi ribosomal P2 ß protein Parasitology 138 2011 736 747
22. G.V. Levy, L.M. Tasso, S.A. Longhi, H.G. Rivello, V. Kytö, and P. Saukko Antibodies against the Trypanosoma cruzi ribosomal P proteins induce apoptosis in HL-1 cardiac cells Int J Parasitol 41 2011 635 644
23. S. Matsui, M.L. Fu, S. Katsuda, M. Hayase, N. Yamaguchi, and K. Teraoka Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits J Mol Cell Cardiol 29 1997 641 655
24. P. López Bergami, J. Scaglione, and M.J. Levin Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic FASEB J 15 2001 2602 2612
25. S.F. Brenière, M.F. Bosseno, F. Noireau, N. Yacsik, P. Liegeard, and C. Aznar Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease Mem Inst Oswaldo Cruz 97 2002 289 295
26. A. Talvani, M.O. Rocha, A.L. Ribeiro, E. Borda, L. Sterin-Borda, and M.M. Teixeira Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease Microbes Infect 8 2006 2459 2464
27. E. Cunha-Neto, V. Coelho, L. Guilherme, A. Fiorelli, N. Stolf, and J. Kalil Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomy-opathy patient J Clin Invest 98 1996 1709 1712
28. L.C. Abel, J. Kalil, and E. Cunha Neto Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin Braz J Med Biol Res 30 1997 1305 1308
29. T. Yoshikawa, A. Baba, and Y. Nagatomo Autoimmune mechanisms underlying dilated cardiomyopathy Circ J 73 2009 602 607
30. A. Baba, T. Yoshikawa, and S. Ogawa Autoantibodies produced against sarcolemmal Na-K-ATPase: Possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy J Am Coll Cardiol 40 2002 1153 1159
31. K. Iizumi, Y. Mikami, M. Hashimoto, T. Nara, Y. Hara, and T. Aoki Molecular cloning and characterization of ouabain-insensitive Na(+)-ATPase in the parasitic protist Trypanosoma cruzi Biochim Biophys Acta 1758 2006 738 746
32. Marcipar IS, Lagier CM. Advances in serological diagnosis of Chagas' disease by using recombinant proteins. En: Rodriguez-Morales A, editor. Current topics in tropical medicine. Rijeka, Croacia: InTech; 2012. Disponible en: http://www.intechopen.com/books/current-topics-in-tropicalmedicine/ advances-in-serological-diagnosis-of-chagas-disease-by-using-recombinant- proteins
33. R. Storino, E. Schapachnik, J. Barousee, J. Leguizamón Palumbo, D. Manigot, and M. De Rosa Clasificación clínica de la miocardiopatía chagásica crónica e historia natural Bol Acad Nac Med B Aires 63 1985 160
34. H. Acquatella Echocardiography in Chagas heart disease Circulation 115 2007 1124 1131
35. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
36. C. Camussone, V. Gonzalez, M.S. Belluzo, N. Pujato, M.E. Ribone, and C.M. Lagier Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis Clin Vaccine Immunol 16 2009 899 905
37. P. Tijssen Processing of data and reporting of results of enzymeimmunoassays. En: Practice and theory of enzimeimmunoassays. Laboratory techniques in biochemistry and molecular biology 1985 Elsevier Ámsterdam 385 421
38. P.F. Wright, E. Nilsson, E.M. Van Rooij, M. Lelenta, and M.H. Jeggo Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis Rev Sci Tech 12 1993 435 450
39. A. Rassi Jr., A. Rassi, W.C. Little, S.S. Xavier, S.G. Rassi, and A.G. Rassi Development and validation of a risk score for predicting death in Chagas' heart disease N Engl J Med 355 2006 799 808
40. M.M. Barbosa, and M.C.P. Nunes Estratificación del riesgo en la enfermedad de Chagas Rev Esp Cardiol 65 Suppl 2 2012 17 21
41. K.B. Axelsen, and M.G. Palmgren Evolution of substrate specificities in the P-type ATPase superfamily J Mol Evol 46 1998 84 101
42. E.S. Borda, and L. Sterin-Borda Antiadrenergic and muscarinic receptor antibodies in Chagas cardiomyopathy Int J Cardiol 54 1996 149 156
43. E. Cunha-Neto, M. Duranti, A. Gruber, B. Zingales, I. De Messias, and N. Stolf Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosinspecific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen Proc Natl Acad Sci USA 92 1995 3541 3545
44. M.O. Masuda, M. Levin, S.F. De Oliveira, P.C. Dos Santos Costa, P.L. Bergami, and N.A. Dos Santos Almeida Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens FASEB J 12 1998 1551 1558
45. E.S. Umezawa, S.F. Bastos, M.E. Camargo, L.M. Yamauchi, M.R. Santos, and A. Gonzalez Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America J Clin Microbiol 37 1999 1554 1560